Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Exp Eye Res ; 164: 55-63, 2017 11.
Artículo en Inglés | MEDLINE | ID: mdl-28789942

RESUMEN

Statins are cholesterol lowering drugs and have shown beneficial effects on glaucoma. With regard to the mechanism of statin action on glaucoma, we investigated the effects of statins on transforming growth factor-beta 2 (TGF-ß2)-induced expression of extracellular matrix (ECM) proteins in human astrocytes of the optic nerve head (ONH) lamina cribrosa (LC). By using primary human ONH astrocytes, we found that both simvastatin and lovastatin inhibited TGF-ß2-mediated expression of ECM proteins such as connective tissue growth factor, collagen I, fibronectin, and plasminogen activator inhibitor-1. Suppression of ECM related proteins is due to inhibition of Smad2/3 activation as statins inhibit TGF-ß2-induced Smad2 phosphorylation and Smad2/3 nuclear accumulation. In ONH astrocytes, TGF-ß2 does not induce MAPK activation. In this study we found an anti-fibrotic effect of statins in human astrocytes of the ONH and identified TGF-ß2 as a mediator of statin action, which may support a beneficial role for statins in blocking glaucomatous axonal damage induced by ECM remodeling.


Asunto(s)
Astrocitos/efectos de los fármacos , Matriz Extracelular/metabolismo , Inhibidores de Hidroximetilglutaril-CoA Reductasas/farmacología , Disco Óptico/metabolismo , Factor de Crecimiento Transformador beta2/fisiología , Análisis de Varianza , Astrocitos/metabolismo , Células Cultivadas , Matriz Extracelular/efectos de los fármacos , Proteínas del Ojo/metabolismo , Humanos , Lovastatina , Disco Óptico/citología , Simvastatina , Factor de Crecimiento Transformador beta2/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA